S100 calcium binding protein A14 (S100A14) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2G9]

CAT#: TA807603AM

S100A14 mouse monoclonal antibody, clone OTI2G9 (formerly 2G9), Biotinylated

Conjugation: Unconjugated Biotin HRP



  View other "OTI2G9" antibodies (4)

Need it in bulk or conjugated?
Get a free quote

CNY 3,990.00


货期*
2周

规格
    • 100 ul

Product images

经常一起买 (3)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Recombinant protein of human S100 calcium binding protein A14 (S100A14), 20 µg
    • 20 ug

CNY 2,900.00
CNY 6,650.00


Transient overexpression lysate of S100 calcium binding protein A14 (S100A14)
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Clone Name OTI2G9
Applications WB
Recommend Dilution WB 1:2000
Reactivity Human, Mouse
Host Mouse
Clonality Monoclonal
Immunogen Full length human recombinant protein of human S100A14 (NP_065723) produced in E.coli.
Formulation PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Concentration 0.5 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Biotin
Storage Condition Store at -20°C as received.
Predicted Protein Size 11.5 kDa
Gene Name S100 calcium binding protein A14
Background This gene encodes a member of the S100 protein family which contains an EF-hand motif and binds calcium. The gene is located in a cluster of S100 genes on chromosome 1. Levels of the encoded protein have been found to be lower in cancerous tissue and associated with metastasis suggesting a tumor suppressor function (PMID: 19956863, 19351828). [provided by RefSeq, Dec 2011]
Synonyms BCMP84; S100A15
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

其它S100 calcium binding protein A14产品

Customer Reviews 
Loading...